Sciences Ltd. Roivant's Net Worth
Sciences Ltd. Roivant's net worth is estimated to be at least $888,568,925.07 as of 01/23/2025. CoreStreet's estimation of Sciences Ltd. Roivant's net worth is based on their sale of stock and current holding of stock.
Sciences Ltd. Roivant is Director at Roivant Sciences Ltd. They have executed at least 13 trades of stock as per SEC Form 4 filings. Their most recent trade was for 16,845,010 units of ROIV stock on 01/13/2025. Their biggest sale was on when they sold units of stock for $. They typically trade 2 times per year.
Total value of insider buys:
- $888,568,925.07
Total value of insider sells:
- $0.00
Most recent insider trade:
- Jan. 13, 2025
Sciences Ltd. Roivant's Insider Trading History
| Immunovant Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Jan. 13, 2025 | Director | 16,845,010 | $20.00 | Buy | $336,900,200.00 |
Oct. 2, 2023 | Director | 1,526,316 | $38.00 | Buy | $58,000,008.00 |
Oct. 6, 2022 | Major Shareholder | 416,667 | $6.00 | Buy | $2,500,002.00 |
Sept. 4, 2020 | Major Shareholder | 380,000 | $33.00 | Buy | $12,540,000.00 |
| Roivant Sciences Ltd | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Jan. 13, 2025 | Director | 16,845,010 | $20.00 | Buy | $336,900,200.00 |
Oct. 2, 2023 | Director | 1,526,316 | $38.00 | Buy | $58,000,008.00 |
Oct. 6, 2022 | Major Shareholder | 416,667 | $6.00 | Buy | $2,500,002.00 |
| Sio Gene Therapies Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Feb. 24, 2020 | Major Shareholder | 5,333,333 | $3.75 | Buy | $19,999,998.75 |
| Myovant Sciences Ltd | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Dec. 16, 2019 | Major Shareholder | 170,000 | $15.13 | Buy | $2,572,100.00 |
Dec. 4, 2019 | Major Shareholder | 75,000 | $17.06 | Buy | $1,279,500.00 |
Dec. 2, 2019 | Major Shareholder | 179,193 | $18.44 | Buy | $3,304,318.92 |
Nov. 25, 2019 | Major Shareholder | 3,500,000 | $15.00 | Buy | $52,500,000.00 |
Nov. 20, 2019 | Major Shareholder | 121,906 | $12.90 | Buy | $1,572,587.40 |